Retail Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Retail Press Releases.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on December 7, 2025

December 7, 2025

Nation's First Nonprofit Business Directory DesiBiz.org Launches to Empower Small Businesses Nationwide

EIN Presswire

December 7, 2025

Pomexpo Brings the Magic of Yalda to the Flatiron District with One-Day Holiday Market on December 13

EIN Presswire

December 7, 2025

USD 9.92 Billion Growth Expected in Europe Commercial Refrigeration Market | UK to Grow at 3.3% CAGR | AMR

EIN Presswire

December 7, 2025

Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025

GlobeNewswire

$SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025$

December 7, 2025

SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025

GlobeNewswire

December 7, 2025

Lime & Lemon Apex Redefines the Dining Scene with an Experience the Triangle Was Waiting For

GlobeNewswire

$Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting$

December 7, 2025

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire

December 7, 2025

Former National Security Analyst Signals a Warning in Recent Presentation: “Most Americans are completely uninformed about China’s ambition and power.”

GlobeNewswire

December 7, 2025

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

GlobeNewswire

December 7, 2025

Rally House Breaks Company Online Sales Record After Electric Sports Weekend

GlobeNewswire

December 7, 2025

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty.

GlobeNewswire

December 7, 2025

WPP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that WPP plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire

December 7, 2025

MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire

December 7, 2025

Kessler Topaz Meltzer & Check, LLP Reminds StubHub Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

GlobeNewswire

$Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting$

December 7, 2025

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

GlobeNewswire

December 7, 2025

ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting

GlobeNewswire

December 7, 2025

ARE INVESTOR LOSSES: Lose Money on Alexandria Real Estate Equities, Inc.? Contact BFA Law before January 26 Securities Class Action Deadline

GlobeNewswire

December 7, 2025

FCX INVESTOR LOSSES: Lose Money on Freeport-McMoRan Inc.? Contact BFA Law before January 12 Securities Class Action Deadline

GlobeNewswire

December 7, 2025

INSP INVESTOR LOSSES: Lose Money on Inspire Medical Systems, Inc.? Contact BFA Law before January 5 Securities Class Action Deadline

GlobeNewswire

December 7, 2025

JEF INVESTOR LOSSES: Lose Money on Jefferies Financial Group Inc.? Contact BFA Law about its Securities Fraud Investigation

GlobeNewswire